What's driving the Glucose Monitoring Devices Market trends? GE HEALTHCARE, MEDTRONIC, ABBOTT, F. HOFFMANN-LA, ROCHE LTD., B. BRAUN MELSUNGEN AG, LIFESCAN, INC., ASCENSIA DIABETES CARE HOLDINGS AG, YPSOMED AG, OMRON CORPORATION, NIPRO CORPORATION

Market Study Report LLC has added a new report on Glucose Monitoring Devices market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defining the dynamics of this industry vertical, this report also incorporates the regional landscape of Glucose Monitoring Devices market in tandem with its competitive terrain.

The global glucose monitoring devices market is expected to reach US$ 21.8 Bn in 2027 from US$ 12.6 Bn in 2018. The market is estimated to grow with a CAGR of 6.4% from 2019-2027.

Request a sample of this premium report at https://www.marketstudyreport.com/request-a-sample/2095827?utm_source=openpr.com&utm_medium=AG

KEY COMPANY PROFILES

o F. HOFFMANN-LA ROCHE LTD.
o B. BRAUN MELSUNGEN AG
o MEDTRONIC
o ABBOTT
o LIFESCAN, INC.
o ASCENSIA DIABETES CARE HOLDINGS AG
o YPSOMED AG
o OMRON CORPORATION
o GE HEALTHCARE
o NIPRO CORPORATION

The market is driven by the factors such as, rising incidence of diabetes, growing geriatric population, increasing prevalence of obesity across the globe, and rapid technological advancement in Glucose Monitoring devices. However, the factors restraining the market growth are high cost of glucose monitoring devices.

Global glucose monitoring devices market was segmented by product and end user. The product segment was further divided as Glucometers, Lancets, Testing Strips and Other Glucose. The test strips segment is expected to dominate its market share in 2027 owing to the rise in the prevalence of the diabetes and rise in number of blood glucose monitoring tests. Based on the end user the glucose monitoring device market is segmented into hospitals and clinics and home care. The homecare held the major market share among the end user segment owing to ease of use, availability, and accessibility of glucose monitoring devices.

Obesity, sedentary lifestyle and improper diet play a major role in increasing diabetes among the population worldwide. Physical activity is important to maintain the blood glucose level. Lack of exercise and unhealthy diet such as diet high in fat and calories increase the risk for the development of obesity and diabetes. Obesity is one of the major problem and the biggest concern in all the communities across the globe. Currently, more than one in two adults and nearly one in six children are obese. Obesity is one of the major issue affect people of all ages and incomes globally.

According to World Health Organization (WHO), in 2016, more than 1.9 billion adults aged 18 years and older were overweight. And out of these over 650 million adults were obese. Therefore, owing to these factors the market is likely to witness growth during the forecast period.

Some of the major primary and secondary sources included in the report for the glucose monitoring devices market are World Health Organization, American Diabetes Association, National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes UK, Centers for Disease Control and Prevention, Chinese Diabetes Society, International Diabetes Federation and others.

Request a discount on standard prices of this premium report at https://www.marketstudyreport.com/check-for-discount/2095827?utm_source=openpr.com&utm_medium=AG

TABLE OF CONTENTS
1. INTRODUCTION
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. GLUCOSE MONITORING DEVICES MARKET LANDSCAPE
5. GLUCOSE MONITORING DEVICES MARKET - KEY MARKET DYNAMICS
6. GLUCOSE MONITORING DEVICES MARKET - GLOBAL MARKET ANALYSIS
7. GLUCOSE MONITORING DEVICES MARKET - REVENUE AND FORECASTS TO 2027
8. GLUCOSE MONITORING DEVICES MARKET - REVENUE AND FORECASTS TO 2027
9. GLUCOSE MONITORING DEVICES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10. INDUSTRY LANDSCAPE
11. GLUCOSE MONITORING DEVICES MARKET, KEY COMPANY PROFILES
11.1. F. HOFFMANN-LA ROCHE LTD.
11.2. B. BRAUN MELSUNGEN AG
11.3. MEDTRONIC
11.4. ABBOTT
11.5. LIFESCAN, INC.
11.6. ASCENSIA DIABETES CARE HOLDINGS AG
11.7. YPSOMED AG
11.8. OMRON CORPORATION
11.9. GE HEALTHCARE
11.10. NIPRO CORPORATION
12. APPENDIX

buying decision on this premium report https://www.marketstudyreport.com/enquiry-before-buying/2095827?utm_source=openpr.com&utm_medium=AG

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.